Diabetic foot ulcer clinical trials
71 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
- Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
- Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
- Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
- Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
- EDX110 Randomized Control Trial for Treatment of DFUs
- Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
- Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
- Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers
- A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
- Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
- Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
- Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
- Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers
- Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
- CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
- Smart Boot Use to Measure Offloading Adherence
- IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
- Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
- Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
- Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
- Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
- Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation
- Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
- Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
- Adapting Lifestyle Offloading for DFUs
- Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
- Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
- A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
- A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
- A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
- Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs
- Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
- Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
- A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
- Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
- Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
- Total Contact Soft Cast in Diabetic Foot Ulcers
- Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
- Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
- Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
- Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
- Diabetic Foot Ulcer Imaging- Study 2
- CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
- Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
- Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
- Mirragen Diabetic Foot Ulcer Study
- DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Diabetic foot ulcer” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.